<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00060515</url>
  </required_header>
  <id_info>
    <org_study_id>RG2133-01</org_study_id>
    <nct_id>NCT00060515</nct_id>
  </id_info>
  <brief_title>RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease</brief_title>
  <official_title>An Open-Label Dose-Escalation Phase I Study to Asses the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RG2133 (2',3',5'-Tri-O-Acetyluridine) in the Treatment of Inherited Mitochondrial Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Repligen Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Repligen Corporation</source>
  <brief_summary>
    <textblock>
      The objective of the study is to determine the safety and tolerability of RG2133 in patients
      with Mitochondrial Disease.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <enrollment>12</enrollment>
  <condition>Mitochondrial Diseases</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>RG2133 (2',3',5'-tri-O-acetyluridine)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Mitochondrial Disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>August 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 7, 2003</study_first_submitted>
  <study_first_submitted_qc>May 7, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2003</study_first_posted>
  <last_update_submitted>August 4, 2005</last_update_submitted>
  <last_update_submitted_qc>August 4, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 5, 2005</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitochondrial Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

